Stay updated on Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC

Sign up to get notified when there's something new on the Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page now displays the ClinicalTrials.gov record for this Phase II head-and-neck cancer trial, including study design, participant criteria, locations, and results measures. The previous 403 error and NIH transition notice are no longer shown.
    Difference
    100%
    Check dated 2026-11-07T13:07:07.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T13:53:43.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in agency content, with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:04:24.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-17T16:44:15.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-10T17:14:57.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the usual content with an error screen. The additions include the 403 message and a basic header, signaling an access restriction rather than substantive content changes.
    Difference
    18%
    Check dated 2026-09-19T20:17:13.000Z thumbnail image

Stay in the know with updates to Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC page.